Urinary kidney injury molecule-1 and the risk of cardiovascular mortality in elderly men

Axel C Carlsson1, Anders Larsson2, Johanna Helmersson-Karlqvist2

  • 1Centre for Family Medicine, Department of Neurobiology, Care Sciences, and Society, Karolinska Institute, Huddinge, Sweden; Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden;

Insights

Higher urinary Kidney Injury Molecule-1 (KIM-1) levels are linked to an increased risk of cardiovascular mortality in men. This association persists even after accounting for traditional cardiovascular risk factors and kidney dysfunction markers.

Area of Science:

  • Nephrology
  • Cardiology
  • Biomarker Research

Background:

  • Kidney injury molecule-1 (KIM-1) is a specific biomarker for acute kidney tubular damage.
  • Community-based data on urinary KIM-1 and cardiovascular mortality risk are limited.

Purpose of the Study:

  • To investigate the association between urinary KIM-1 levels and cardiovascular mortality.
  • To determine if KIM-1 is an independent predictor of cardiovascular death.

Main Methods:

  • Prospective study of 590 men (mean age 77) from the Uppsala Longitudinal Study of Adult Men.
  • Median follow-up of 8.1 years, with adjustment for cardiovascular risk factors and kidney dysfunction markers (eGFR, albuminuria).

Main Results:

  • Higher urinary KIM-1/creatinine was associated with increased cardiovascular mortality risk (HR per SD increase, 1.27; P=0.01).
  • A combination of high KIM-1, low eGFR, and albuminuria indicated a >8-fold increased risk of cardiovascular mortality (HR, 8.56; P<0.001).

Conclusions:

  • Elevated urinary KIM-1 may indicate a predisposition to higher cardiovascular mortality risk.
  • KIM-1's predictive value is independent of established cardiovascular risk factors, eGFR, and albuminuria.
  • Further research is needed to evaluate KIM-1's clinical utility.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
557
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.4K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.2K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.7K
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.3K